Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets extend gains
Mon, 11 May 01:30 pm

The Indian stock markets continued to trade in green in the post noon trading session. All the sectoral indices are trading firm with banking and auto sectors witnessing maximum buying interest.

The BSE-Sensex is trading up by 368.9 points (1.4%) while the The 50 share NSE-Nifty is also quoting up by 118 points (1.4%). BSE Mid Cap index is trading up by 1.8% and the BSE Small Cap index is trading up by 1.2%. The rupee was trading at 63.9 to the US dollar at the time of writing. Gold prices are trading at Rs 26,855 levels and silver prices are trading at Rs 37,881 levels. Crude oil is trading at Rs 3,815 levels.

Food and tobacco stocks are trading mixed with Wadala Commodities and Godfrey Phillips being the leading gainers. As per a leading financial daily, FMCG firm GSK Consumer Healthcare Ltd reported a 14.6% increase in net profit at Rs 1.97 bn for the quarter ended March 2015. In the year ago quarter the company had reported a profit of Rs 1.72 bn. Net sales of the company were up by 8% at Rs 11.65 bn in the quarter against Rs 10.79 bn in the corresponding period last year. The performance drivers enabling the jump in quarterly results, as company stated, were market penetration, greater access to products, and cost efficiency. In a separate filing, the company's Board of director has recommended a dividend at the rate of Rs 55 per share of Rs 10 each. The stock of GSK Consumer is trading down by 0.3%.

Paint stocks are also trading mixed with Jenson and Nicholson and Asahi Songwon being the top gainers. Kansai Nerolac Paints, the second largest paint company in India, is all set to invest Rs 3.5 bn to set up a new plant in Gujarat. The manufacturing unit will have a capacity of 42,000 tonnes per year, which is expandable in phases. The company also on Saturday reported a 34.6% increase in standalone net profit at Rs 0.6 bn for the fourth quarter ended March 31 as against 0.45 bn in the corresponding quarter for the last fiscal. Net sales during the quarter stood at Rs 8 bn, an increase of 7.71% compared with Rs 7.5 bn in the year ago quarter. The Board of Directors of the company also recommended a dividend of Rs 1.40 per share.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets extend gains". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.